Dr Reddys Laboratories Share Price Today - Live Blog for June 12, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.48% decline, and it currently trades at ₹1,356.55 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.07%, reaching the current market price of ₹1,363.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.46%. With its current market price standing at ₹1,362.20 per share, this stock is garnering increased attention from the investment community.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.20%. At this moment, it's actively trading at ₹1,356.65, presenting an enticing opportunity for those in the market.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.34% gain, with the share price now at ₹1,354.60. Notably, the stock's PE ratio stands at 19.9200, and its Return on Equity (ROE) is 16.8559%.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.43% recently. As of now, this stock is actively trading at a current market price of ₹1,350.95 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,345.70. Investors are carefully considering their positions and seeking insights into the stock's future performance.

With a -0.54% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,348.10. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.9200, while the industry PE is 34.5835.

Dr Reddys Laboratories Ltd shares experienced a -0.45% reduction, with the current market price at ₹1,354.55. Investors are carefully considering their positions and seeking insights into the stock's future performance.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.07% in its share price, and it currently trades at ₹1,361.50 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a -0.16% drop in its share price and is currently trading at ₹1,362.45. With the stock's PE at 19.9200 and the industry PE at 34.5835, investors are weighing their options.

Dr Reddys Laboratories Ltd witnessed a -0.02% drop in its share price and is currently trading at ₹1,364.40. With the stock's PE at 19.9200 and the industry PE at 34.5835, investors are weighing their options.

Dr Reddys Laboratories Ltd's share price rallied by 0.01%, reaching the current market price of ₹1,364.55. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.01%, and as of now, it's trading at ₹1,364.55 per share. This upward trajectory is attracting keen interest from investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.10%, signalling a challenging period. Currently trading at ₹1,364.15, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.09% recently. As of now, this stock is actively trading at a current market price of ₹1,365.50 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.29% decline, and it currently trades at ₹1,364.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.14%, reaching a current market price of ₹1,366.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd observed a remarkable 0.15% surge in its share price and is presently trading at ₹1,368.90. The increased investor interest is driving this surge.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,366.90. The stock is currently trading at a PE of 19.9200, while the industry PE is 34.5835, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,367.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

After a notable 0.16% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,365.80. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

With a -0.18% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,363.60. The stock is currently trading at a PE of 19.9200, while the industry PE is 34.5835, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.18%, signalling a challenging period. Currently trading at ₹1,364.60, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.21% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,367.10. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.9200, while the industry PE is 34.5835.

Dr Reddys Laboratories Ltd share price surged by 1.41%. With its current market price standing at ₹1,370.00 per share, this stock is garnering increased attention from the investment community.